[1] Wu Z, Jiang S, Chen Y. Non-coding RNA and Drug resistance in cholangiocarcinoma[J]. Noncoding RNA Res, 2024, 9(1):194-202. DOI:10.1016/j.ncrna.2023.11.003.
[2] Tomishima K, Suzuki A, Ito K, et al. Remarkable tumor shrinkage in hilar biliary cholangiocarcinoma confirmed by peroral cholangioscopy following neoadjuvant chemotherapy[J]. Endoscopy, 2024, 56(S 01):E85-e86. DOI:10.1055/a-2234-4355.
[3] Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018,15(2):95-111. DOI:10.1038/nrclinonc. 2017.157.
[4] Markasz L, Mobini-Far H, Sindelar R. Collagen type IV alpha 1 chain (COL4A1) expression in the developing human lung[J]. BMC Pulm Med, 2024, 24(1):75. DOI:10.1186/s12890-024-02875-4.
[5] Wang Z, Chen C, Shu J, et al. Single-cell N(6)-methyladenosine-related genes function within the tumor microenvironment to affect the prognosis and treatment sensitivity in patients with gastric cancer[J]. Cancer Cell Int, 2024, 24(1):44. DOI:10.1186/s12935-024-03227-2.
[6] Breedveld G, de Coo IF, Lequin MH, et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly[J]. J Med Genet, 2006, 43(6):490-495. DOI:10.1136/jmg.2005.035584.
[7] Coste T, Vincent-Delorme C, Stichelbout M, et al. COL4A1/COL4A2 and inherited platelet disorder gene variants in fetuses showing intracranial hemorrhage[J]. Prenat Diagn, 2022, 42(5):601-610. DOI:10.1002/pd.6113.
[8] Kuo DS, Labelle-Dumais C, Gould DB. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets[J]. Hum Mol Genet, 2012, 21(R1):R97-110. DOI:10.1093/hmg/dds346.
[9] Kuuluvainen L, Mönkäre S, Kokkonen H, et al. COL4A1 and COL4A2 Duplication Causes Cerebral Small Vessel Disease With Recurrent Early Onset Ischemic Strokes[J]. Stroke, 2021, 52(10):e624-e625. DOI:10.1161/strokeaha.120.033864.
[10]Cui X, Shan T, Qiao L. Collagen type IV alpha 1 (COL4A1) silence hampers the invasion, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway[J]. Bioengineered, 2022, 13(4):8972-8981. DOI:10.1080/21655979.2022.2053799.
[11]Wang T, Jin H, Hu J, et al. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling[J]. J Exp Clin Cancer Res, 2020, 39(1):148. DOI:10.1186/s13046-020-01650-7.
|